Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients

Luit Penninga; Ida Elisabeth Irene Penninga; Christian H Møller; Martin Iversen; Daniel A Steinbrüchel; Christian Gluud

doi:10.1002/14651858.CD008817.pub2

Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients

Luit Penninga, Ida Elisabeth Irene Penninga, Christian H Møller, Martin Iversen, Daniel A Steinbrüchel, Christian Gluud

95 Citationer (Scopus)

Abstract

Lung transplantation is a well-accepted treatment for people with most end-stage lung diseases. Although both tacrolimus and cyclosporin are used as primary immunosuppressive agents in lung transplant recipients, it is unclear which of these drugs is better in reducing rejection and death without causing adverse effects.

Originalsprog	Engelsk
Tidsskrift	Cochrane Database of Systematic Reviews
Vol/bind	5
Sider (fra-til)	CD008817
ISSN	1469-493X
DOI	https://doi.org/10.1002/14651858.CD008817.pub2
Status	Udgivet - 2013

Adgang til dokumentet

10.1002/14651858.CD008817.pub2

Citationsformater

@article{d605630d76c846b9a0ee65de04db6a3e,

title = "Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients",

abstract = "Lung transplantation is a well-accepted treatment for people with most end-stage lung diseases. Although both tacrolimus and cyclosporin are used as primary immunosuppressive agents in lung transplant recipients, it is unclear which of these drugs is better in reducing rejection and death without causing adverse effects.",

author = "Luit Penninga and Penninga, {Ida Elisabeth Irene} and M{\o}ller, {Christian H} and Martin Iversen and Steinbr{\"u}chel, {Daniel A} and Christian Gluud",

year = "2013",

doi = "10.1002/14651858.CD008817.pub2",

language = "English",

volume = "5",

pages = "CD008817",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "Update Software Ltd",

}

TY - JOUR

T1 - Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients

AU - Penninga, Luit

AU - Penninga, Ida Elisabeth Irene

AU - Møller, Christian H

AU - Iversen, Martin

AU - Steinbrüchel, Daniel A

AU - Gluud, Christian

PY - 2013

Y1 - 2013

N2 - Lung transplantation is a well-accepted treatment for people with most end-stage lung diseases. Although both tacrolimus and cyclosporin are used as primary immunosuppressive agents in lung transplant recipients, it is unclear which of these drugs is better in reducing rejection and death without causing adverse effects.

AB - Lung transplantation is a well-accepted treatment for people with most end-stage lung diseases. Although both tacrolimus and cyclosporin are used as primary immunosuppressive agents in lung transplant recipients, it is unclear which of these drugs is better in reducing rejection and death without causing adverse effects.

U2 - 10.1002/14651858.CD008817.pub2

DO - 10.1002/14651858.CD008817.pub2

M3 - Journal article

C2 - 23728681

SN - 1469-493X

VL - 5

SP - CD008817

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

ER -

Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater